Marker Therapeutics (MRKR) is The Notable Biotech Stock To Watch on Friday

It is almost always a good idea for investors to consider tracking those stocks which might have made substantial gains during premarket trading.

It is an indication of what the trading day might bring and hence, it could be a good move to start tracking the Marker Therapeutics Inc (NASDAQ: MRKR) stock this morning. The Marker stock has already gone up by as much as 41% in premarket trading today. The rally in the stock has come about after it emerged that the company’s Chief Executive Officer and President Peter L. Hoang purchased Marker stock.

It was disclosed that Hoang bought as many as 142,857 Marker shares on Tuesday with an average cost of $1.75 each. Such a move usually indicates that the management of the company is confident about its prospects and hence, it can lead to increased optimism among investors as well. It now remains to be seen if the Marker stock can continue to gain on the back of this development.

Michael Rowels

Weekend Contributor.Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.